Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19404953 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Atorvastatin;   Drug: Placebo atorvastatin

Indicates status has not been verified in more than two years